
Radio and PodcastLive Radio & Podcasts
TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2
In part two of this series, Dr. Tesha Monteith and Dr. Brett Lauring discuss the clinical trial design, including the objectives and methods. Read more about this abstract on the AAN website .
About This Episode
TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2 is an episode from Neurology Minute by Anna Rehbein. In part two of this series, Dr. Tesha Monteith and Dr. Brett Lauring discuss the clinical trial design, i...
This episode belongs to Neurology Minute.
Use the player on this page to stream the episode online.
Published Apr 14, 2026, 03:33 long, audio available.
Questions About This Episode
What is TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2 about?
In part two of this series, Dr. Tesha Monteith and Dr. Brett Lauring discuss the clinical trial design, including the objectives and methods. Read more about this abstract on the AAN website .
Where can I listen to TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2?
You can listen to TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2 online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2 from?
TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2 is an episode from Neurology Minute by Anna Rehbein.
How long is this episode?
This episode is 03:33 long.
When was this episode published?
This episode was published on Apr 14, 2026.
Can I save TRPM8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine - Part 2 for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Neurology Minute?
Yes. This page shows related episodes from Neurology Minute when more episodes are available from the podcast feed.